Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Renal Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04113486
What this trial is testing

Expression Levels of Nicotinamide Metabolism-related Protein (NMAP) in Newly Diagnosed Renal Cancer and Non-renal Cancer Populations

Who this might be right for
Carcinoma, Renal Cell
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 400
Not applicableStudy completedNCT04368546
What this trial is testing

Sunitinib Treatment on Tissue Sodium Accumulation (TSS2)

Who this might be right for
Renal Cell Cancer MetastaticHypertensionSodium Imbalance
Charite University, Berlin, Germany 6
Large-scale testing (Phase 3)Looking for participantsNCT07092566
What this trial is testing

R.E.C.K vs Exparel in Robotic Nephrectomy

Who this might be right for
Renal CarcinomaNephrectomy / MethodsPain Management
Wake Forest University Health Sciences 170
Testing effectiveness (Phase 2)UnknownNCT00890110
What this trial is testing

Autologous Vaccination of Stage 4 Renal Cell Carcinoma Combined With Sunitinib

Who this might be right for
Renal Cell Cancer
Hadassah Medical Organization 13
Not applicableStudy completedNCT04316520
What this trial is testing

Ketogenic Diet for Patients Receiving Treatment for Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cancer
University Hospital, Angers 20
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Large-scale testing (Phase 3)Study completedNCT00018941
What this trial is testing

Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT03866382
What this trial is testing

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Who this might be right for
Bladder AdenocarcinomaBladder Clear Cell AdenocarcinomaBladder Mixed Adenocarcinoma+42 more
National Cancer Institute (NCI) 314
Not applicableLooking for participantsNCT06194669
What this trial is testing

Mechanisms of Somatic Mutation and Tumor Initiation in Pre-malignant Kidney Tubule Cells

Who this might be right for
Carcinoma, Renal CellVon Hippel-Lindau Disease
IRCCS San Raffaele 50
Early research (Phase 1)WithdrawnNCT03189186
What this trial is testing

Phase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas

Who this might be right for
Renal Cell CarcinomaMetastatic Kidney Cancer
University of California, Irvine
Large-scale testing (Phase 3)Study completedNCT00606632
What this trial is testing

Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody

Who this might be right for
Renal Cell CarcinomaKidney Cancer
Heidelberg Pharma AG 226
Very early researchStudy completedNCT00276835
What this trial is testing

Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)
Northwestern University 15
Early research (Phase 1)Study completedNCT00351949
What this trial is testing

IMP321 Phase 1 Trial in Metastatic Renal Cell Carcinoma (MRCC)

Who this might be right for
Stage IV Renal Cell Carcinoma
Immutep S.A.S. 24
Large-scale testing (Phase 3)Study completedNCT00003126
What this trial is testing

Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer

Who this might be right for
Kidney Cancer
Loyola University 69
Testing effectiveness (Phase 2)Looking for participantsNCT06161532
What this trial is testing

Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...

Who this might be right for
Small Cell Carcinoma of the BladderSmall Cell Carcinoma of the Urinary TractSquamous Cell Carcinoma of the Bladder+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00045487
What this trial is testing

Erlotinib in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Cancer
The University of Texas Health Science Center at San Antonio 41
Testing effectiveness (Phase 2)Study completedNCT04718584
What this trial is testing

The Efficacy and Safety of LDP in Patients With Urinary and Male Genital Tumors

Who this might be right for
Bladder CancerRenal CarcinomaAdvanced Penile Carcinoma
Dragonboat Biopharmaceutical Company Limited 27
Not applicableWithdrawnNCT06603155
What this trial is testing

Time Restricted Eating (TRE) in Metastatic Head and Neck Squamous Cell Cancer (mHNSCC) or Unresectable or Metastatic Renal Cell Carcinoma (RCC)

Who this might be right for
Metastatic Head-and-neck Squamous-cell CarcinomaUnresectable Renal Cell CarcinomaMetastatic Renal Cell Carcinoma
Duke University
Early research (Phase 1)Study completedNCT00039052
What this trial is testing

Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer

Who this might be right for
Breast CancerKidney CancerLung Cancer
Neurocrine Biosciences
Testing effectiveness (Phase 2)WithdrawnNCT03927248
What this trial is testing

PAC-1 for Treatment of Refractory, Metastatic Kidney Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma
HealthPartners Institute
Next Page
60